On the proper use of the crossover design in clinical trials: part 18 of a series on evaluation of scientific publications
- PMID: 22567063
- PMCID: PMC3345345
- DOI: 10.3238/arztebl.2012.0276
On the proper use of the crossover design in clinical trials: part 18 of a series on evaluation of scientific publications
Abstract
Background: Many clinical trials have a crossover design. Certain considerations that are relevant to the crossover design, but play no role in standard parallel-group trials, must receive adequate attention in trial planning and data analysis for the results to be of scientific value.
Methods: The authors present the basic statistical methods required for the analysis of crossover trials, referring to standard statistical texts.
Results: In the simplest and most common scenario, a crossover trial involves two treatments which are consecutively administered in each patient recruited in the study. The main purpose served by the design is to provide a basis for separating treatment effects from period effects. This is achieved via computing the treatment effects separately in two sequence groups formed via randomization. The differences between treatment effects can be assessed by means of a standard t-test for independent samples using the intra-individual differences between the outcomes in both periods as the raw data. The existence of carryover effects must be ruled out for this method to be valid. This assumption is usually checked using a pre-test, which is also described in this article. Finally, we briefly discuss the use of nonparametric tests instead of t-tests and more complicated designs with more than two test periods and/or treatments.
Conclusion: Crossover trials in which the results are not analyzed separately by sequence group are of limited, if any, scientific value. It is also essential to guard against carryover effects. Whenever ignoring such effects proves unjustified, the treatment effect must be analyzed solely via an analysis of the data obtained during the first trial period. Even the use of this restricted dataset yields results whose validity is not beyond question.
Figures
Similar articles
-
The future of Cochrane Neonatal.Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12. Early Hum Dev. 2020. PMID: 33036834
-
Carryover negligibility and relevance in bioequivalence studies.Pharm Stat. 2015 Sep-Oct;14(5):400-8. doi: 10.1002/pst.1699. Epub 2015 Jul 14. Pharm Stat. 2015. PMID: 26175204
-
Establishing equivalence or non-inferiority in clinical trials: part 20 of a series on evaluation of scientific publications.Dtsch Arztebl Int. 2012 Oct;109(41):674-9. doi: 10.3238/arztebl.2012.0674. Epub 2012 Oct 12. Dtsch Arztebl Int. 2012. PMID: 23264808 Free PMC article. Review.
-
Randomized, placebo-controlled, parallel group versus crossover study designs for the study of dementia in Parkinson's disease.Control Clin Trials. 2002 Apr;23(2):111-26. doi: 10.1016/s0197-2456(01)00207-0. Control Clin Trials. 2002. PMID: 11943439
-
A critique of recent research on the two-treatment crossover design.Control Clin Trials. 1989 Sep;10(3):237-43. doi: 10.1016/0197-2456(89)90065-2. Control Clin Trials. 1989. PMID: 2676339 Review.
Cited by
-
Enjoyment and Affective Responses to Moderate and High-Intensity Exercise: A Randomized Controlled Trial in Individuals with Subsyndromal PTSD.Sports (Basel). 2024 May 20;12(5):138. doi: 10.3390/sports12050138. Sports (Basel). 2024. PMID: 38787007 Free PMC article.
-
Effect of 0.01% atropine combined with orthokeratology lens on axial elongation: a 2-year randomized, double-masked, placebo-controlled, cross-over trial.Front Med (Lausanne). 2024 Apr 23;11:1358046. doi: 10.3389/fmed.2024.1358046. eCollection 2024. Front Med (Lausanne). 2024. PMID: 38716420 Free PMC article.
-
Quality of Life and Its Association With Time in Range Among People With Type 2 Diabetes Mellitus Following Different Dietary Interventions: A Crossover Clinical Trial.Cureus. 2024 Apr 4;16(4):e57624. doi: 10.7759/cureus.57624. eCollection 2024 Apr. Cureus. 2024. PMID: 38707009 Free PMC article.
-
High-dose oral thiamine versus placebo for chronic fatigue in patients with primary biliary cholangitis: A crossover randomized clinical trial.PLoS One. 2024 Mar 29;19(3):e0301354. doi: 10.1371/journal.pone.0301354. eCollection 2024. PLoS One. 2024. PMID: 38551983 Free PMC article. Clinical Trial.
-
Effects of online tDCS and hf-tRNS on reading performance in children and adolescents with developmental dyslexia: a study protocol for a cross sectional, within-subject, randomized, double-blind, and sham-controlled trial.Front Neurol. 2024 Mar 12;15:1338430. doi: 10.3389/fneur.2024.1338430. eCollection 2024. Front Neurol. 2024. PMID: 38533416 Free PMC article.
References
-
- Jones B, Kenward MG. 2nd edition. Boca Raton: Chapman & Hall/CRC; 2003. Design and analysis of cross-over trials.
-
- Karst M, Salim K, Burstein S, Conrad I, Hoy L, Schneider U. Analgesic effect of the synthetic cannabinoid CT-3 on chronic neuropathic pain. A randomized controlled trial. JAMA. 2003;290:1757–1762. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical